Try from €0.25 / day
A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC
Elan and stockholders of its subsidiary, Athena Diagnostics, have agreed to sell all outstanding stock of Athena Diagnostics to Behrman Capital for $122m (€122.6m).
Mon, 25 Nov, 2002
News
Tuesday, May 12, 2026 - 7:00 PM
Tuesday, May 12, 2026 - 4:00 PM
Tuesday, May 12, 2026 - 12:00 PM